알림
뒤로


    Driving Biomedical Research and

   Diagnosis Since 2001


At immunostep we have been innovating since 2001 to develop comprehensive  products that contribute to

improve performance in key areas of clinical research and diagnostic development. Our goal is to improve

research and  diagnostic performance by innovating and adapting new technology to  collaborate building

 meaningful clinical investigation.

Leading-edge research products to
increase the analysis potential.

Leading-edge research products to
increase the analysis potential.

Extensive Research, Development
and Innovation (R&D&I) Programme.

Extensive Research, Development
and Innovation (R&D&I) Programme.

Seeking efficency and offering
alternative to traditional solutions.

Seeking efficency and offering
alternative to traditional solutions.

Succesful technology licensing and
meaningful worldwide collaborations.

Succesful technology licensing and
meaningful worldwide collaborations.


    Biotechnology Innovation


We work to achieve customer satisfaction through quality and differentiation of our products. We are

constantly learning and developing as a company and, in the same way, we expect our products and our way

of working to be constantly improving for the benefit of all our collaborators. 

UNDER ISO13485:2016 CERTIFIED QUATILY MANAGEMENT SYSTEM.

PRESENT IN 20+ COUNTRIES WORLDWIDE

+500 PUBLICATIONS FEAUTURING IMMUNOSTEP PRODUCTS

UNDER ISO13485:2016 CERTIFIED QUATILY 

MANAGEMENT SYSTEM.

PRESENT IN 20+ COUNTRIES WORLDWIDE

+500 PUBLICATIONS FEAUTURING IMMUNOSTEP

PRODUCTS

AT THE LEADING - 

EDGE OF TECHNOLOGY

IN RESEARCH AREAS 

OF DEVELOPMENT

P R O D U C T S

ANTIBODIES


Immunostep has long been working to find and develop the best antibodies for Flow Cytometry.

This has allowed us to obtain monoclonal antibodies that afford a better fluorescence intensity than other products available on the market. Moreover, Immunostep subjects all its antibodies to stringent testing such as repeatability, diagnostic sensitivity, analytical sensitivity or linearity, specificity and titre, thereby guaranteeing that all its products are suitable for diagnosis and research.

APOPTOSIS


Apoptosis ("normal" or "programmed" cell death) is the physiological process by

which unwanted or useless cells are eliminated during development and other normal 

biological processes.

Flow Cytometry Solution


Immunostep has long been working to find and develop the best antibodies for Flow Cytometry.

This has allowed us to obtain monoclonal antibodies that afford a better fluorescence intensity than other products available on the market. Moreover, Immunostep subjects all its antibodies to stringent testing such as repeatability, diagnostic sensitivity, analytical sensitivity or linearity, specificity and titre, thereby guaranteeing that all its products are suitable for diagnosis and research.